0.34 USD
0.000.00%
盘后 0.35 0.00%
2026-09-16
市值
$1.89M
市盈率
—
EPS
-38.75
股息率
—
52 周区间
0.32 – 42.60
成交量
2.14M
Beta
-0.36
目标价
60.00
52W 低 0.3252W 高 42.60
价格走势
公司简介
Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre...